The history of Hogne

HOGNE AB, founded in the summer of 2020, emerged from the vision of Susanne and Peter Åhnblad – a specialized nurse and medical ENT doctor, respectively – who have been successfully operating an Ear-, Nose- & Throat (ENT) Clinic in Nacka, Stockholm, Sweden since 2010. With a combined experience of over 50 years in the medical and inventing field, they identified a global market gap for a user-friendly nose blood stopper.
‍
Having previously pioneered a groundbreaking nasal rinser that achieved commercial success in Swedish pharmacies and international markets such as the USA, Korea, and Japan, the couple sold their company along with the rights to the nasal rinser to a prominent US corporation in late 2017. This marked a pivotal moment as they shifted their focus towards developing a nose plug that could efficiently stop nosebleeds without blocking nasal breathing.
‍
Nosebleeds, apart from being bothersome and staining clothes, present unique challenges. Few individuals are aware of the most effective and fastest ways to control blood flow. Identifying the exact source of bleeding is often challenging, and common practices such as stuffing toilet paper or cotton into the nose can trigger further bleeding when removed. Furthermore, there persists a misconception that medical professionals possess a range of methods to cure nosebleeds.
‍
In 2019, after extensive prototype development and testing, HOGNE AB was established. Åsa and Tommy Rönngren joined forces with Susanne and Peter Åhnblad, transferring all assets and rights of the NosePlug® to HOGNE. This strategic move was aimed at creating a specialized company entirely committed to this innovative project. With Åsa and Tommy Rönngren bringing deep expertise in the investment management industry, banking, and finance, HOGNE had created a team with expertise in medicine, medical devices, company management, and finance. Notably, both couples had already collaborated successfully in other medical device company since 2010, ensuring a seamless and efficient partnership.
‍
The birth of HOGNE represents a culmination of experience, professionalism, and unwavering dedication to improving the lives of individuals suffering from nosebleeds and other ENT conditions.